Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8329)
All Articles published online
|
Publishing Process of This Article
|
Mar 7, 2015 (publication date) through Mar 31, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang X, Song YF, Lu HN, Wang DP, Zhang XS, Huang SL, Sun BL, Huang ZG. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas. World J Gastroenterol 2015; 21(9): 2629-2637 [PMID: 25759530 DOI: 10.3748/wjg.v21.i9.2629] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i9/2629.htm |
| Number | Citing Articles |
| 1 |
Annamaria Chiara Santini, Giancarlo Giovane, Adelaide Auletta, Angelina Di Carlo, Alfonso Fiorelli, Letizia Cito, Carlo Astarita, Antonio Giordano, Roberto Alfano, Antonia Feola, Marina Di Domenico. Translational Research and Plasma Proteomic in Cancer. Journal of Cellular Biochemistry 2016; 117(4): 828 doi: 10.1002/jcb.25413
|
| 2 |
Bingsheng Li, Aihua Gan, Xiaolong Chen, Xinying Wang, Weifeng He, Xiaohui Zhang, Renxiang Huang, Shuzhu Zhou, Xiaoxiao Song, Angao Xu, John Green. Diagnostic Performance of DNA Hypermethylation Markers in Peripheral Blood for the Detection of Colorectal Cancer: A Meta-Analysis and Systematic Review. PLOS ONE 2016; 11(5): e0155095 doi: 10.1371/journal.pone.0155095
|
| 3 |
Xiang Li, Dan Song, Song Su, Xiaobo He, Fengyu Cao, Chao Yang, Kai Li, Shuoyang Huang, Changhua Li, Chenhong Wang, Aikang Zhang, Pengcheng Pang, Yongbin Zheng. Critical role of guanylate binding protein 5 in tumor immune microenvironment and predictive value of immunotherapy response. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.984615
|
| 4 |
Mohsen Mohammadi, Seyed-Mojtaba Jafari, Mohammad-Ali Mohaghegh, Ali Ghasemi, Niloofar Momenzadeh. Comparison of SFRP2 promoter methylation in stool sample and cfDNA regarding patients with colorectal cancer. Comparative Clinical Pathology 2018; 27(1): 155 doi: 10.1007/s00580-017-2568-2
|
| 5 |
Guodong Zhao, Yong Ma, Hui Li, Shiming Li, Yun Zhu, Xiaoyu Liu, Shangmin Xiong, Yi Liu, Jin Miao, Sujuan Fei, Minxue Zheng, Xiangwei Zhao. A novel plasma based early colorectal cancer screening assay base on methylated SDC2 and SFRP2. Clinica Chimica Acta 2020; 503: 84 doi: 10.1016/j.cca.2020.01.010
|
| 6 |
Hatim Boughanem, Jesús pilo, Libia Alejandra García-Flores, Isabel Arranz, María Ramos-Fernandez, María Ortega-Castan, Ana B. Crujeiras, Juan Sandoval, Manuel Macias-Gonzalez. Identification of epigenetic silencing of the SFRP2 gene in colorectal cancer as a clinical biomarker and molecular significance. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05329-x
|
| 7 |
Liang Min, Jinghua Chen, Meihong Yu, Deliang Liu. Using Circulating Tumor DNA as a Novel Biomarker to Screen and Diagnose Colorectal Cancer: A Meta-Analysis. Journal of Clinical Medicine 2023; 12(2): 408 doi: 10.3390/jcm12020408
|
| 8 |
Hui Li, Zhenzhen Wang, Guodong Zhao, Yong Ma, Ying Chen, Qi Xue, Minxue Zheng, Sujuan Fei. Performance of a MethyLight assay for methylated SFRP2 DNA detection in colorectal cancer tissue and serum. The International Journal of Biological Markers 2019; 34(1): 54 doi: 10.1177/1724600818820536
|
| 9 |
Amjad Mahasneh, Fawaz Al-Shaheri, Eshraq Jamal. Molecular biomarkers for an early diagnosis, effective treatment and prognosis of colorectal cancer: Current updates. Experimental and Molecular Pathology 2017; 102(3): 475 doi: 10.1016/j.yexmp.2017.05.005
|
| 10 |
Anastasia E. Kottorou, Anna G. Antonacopoulou, Foteinos-Ioannis D. Dimitrakopoulos, Georgia Diamantopoulou, Chaido Sirinian, Melpomeni Kalofonou, Theodoros Theodorakopoulos, Chrysa Oikonomou, Evangelos C. Katsakoulis, Angelos Koutras, Thomas Makatsoris, Nikos Demopoulos, Georgia Stephanou, Michalis Stavropoulos, Konstantinos C. Thomopoulos, Haralabos P. Kalofonos. Deregulation of methylation of transcribed-ultra conserved regions in colorectal cancer and their value for detection of adenomas and adenocarcinomas. Oncotarget 2018; 9(30): 21411 doi: 10.18632/oncotarget.25115
|
| 11 |
Jun Yu, Yang Xie, Mengying Li, Fenfang Zhou, Zhenyang Zhong, Yuting Liu, Feng Wang, Jian Qi. Association between SFRP promoter hypermethylation and different types of cancer: A systematic review and meta‑analysis. Oncology Letters 2019; doi: 10.3892/ol.2019.10709
|
| 12 |
Hyung-Yoon Yoon, Sung Pil Seo, Sang Keun Lee, Ho Won Kang, Won Tae Kim, Dong Hee Ryu, Seok-Joong Yun, Sang-Cheol Lee, Wun-Jae Kim, Yong-June Kim. Association of GATA5 methylation with clinocopathological characteristics in non-muscle invasive bladder cancer. Journal of Biomedical Research 2015; 16(4): 146 doi: 10.12729/jbr.2015.16.4.146
|
| 13 |
Mai-Britt Worm Ørntoft. Review of Blood-Based Colorectal Cancer Screening: How Far Are Circulating Cell-Free DNA Methylation Markers From Clinical Implementation?. Clinical Colorectal Cancer 2018; 17(2): e415 doi: 10.1016/j.clcc.2018.02.012
|
| 14 |
Vera Constâncio, Sandra P. Nunes, Rui Henrique, Carmen Jerónimo. DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types. Cells 2020; 9(3): 624 doi: 10.3390/cells9030624
|
| 15 |
Manish Pratap Singh, Sandhya Rai, Shradha Suyal, Sunil Kumar Singh, Nand Kumar Singh, Akash Agarwal, Sameer Srivastava. Genetic and epigenetic markers in colorectal cancer screening: recent advances. Expert Review of Molecular Diagnostics 2017; 17(7): 665 doi: 10.1080/14737159.2017.1337511
|
| 16 |
Nadia El Kadmiri. Advances in Early Detection of Colorectal Cancer: A Focus on Non-invasive Biomarkers. Current Drug Targets 2021; 22(9): 1043 doi: 10.2174/1389450122666210303100048
|
| 17 |
Chi Chun Wong, Weilin Li, Bertina Chan, Jun Yu. Epigenomic biomarkers for prognostication and diagnosis of gastrointestinal cancers. Seminars in Cancer Biology 2019; 55: 90 doi: 10.1016/j.semcancer.2018.04.002
|
| 18 |
Barbara Kinga Barták, Alexandra Kalmár, Bálint Péterfia, Árpád V. Patai, Orsolya Galamb, Gábor Valcz, Sándor Spisák, Barnabás Wichmann, Zsófia Brigitta Nagy, Kinga Tóth, Zsolt Tulassay, Péter Igaz, Béla Molnár. Colorectal adenoma and cancer detection based on altered methylation pattern of SFRP1, SFRP2, SDC2, and PRIMA1 in plasma samples. Epigenetics 2017; 12(9): 751 doi: 10.1080/15592294.2017.1356957
|
| 19 |
Isadora Bernardo David de Oliveira, Rosario Dominguez Crespo Hirata. Circulating cell-free DNA as a biomarker in the diagnosis and prognosis of colorectal cancer. Brazilian Journal of Pharmaceutical Sciences 2018; 54(1) doi: 10.1590/s2175-97902018000117368
|
| 20 |
Jiaolin Liu, Fanlu Lin, Xin Wang, Chaopeng Li, Qiangyuan Qi. GATA binding protein 5-mediated transcriptional activation of transmembrane protein 100 suppresses cell proliferation, migration and epithelial-to-mesenchymal transition in prostate cancer DU145 cells. Bioengineered 2022; 13(4): 7972 doi: 10.1080/21655979.2021.2018979
|
| 21 |
Barbara Kinga Barták, Tamás Fodor, Alexandra Kalmár, Zsófia Brigitta Nagy, Sára Zsigrai, Krisztina Andrea Szigeti, Gábor Valcz, Péter Igaz, Magdolna Dank, István Takács, Béla Molnár. A Liquid Biopsy-Based Approach for Monitoring Treatment Response in Post-Operative Colorectal Cancer Patients. International Journal of Molecular Sciences 2022; 23(7): 3774 doi: 10.3390/ijms23073774
|
| 22 |
Kaisa Cui, Xiaohan Wu, Liang Gong, Surui Yao, Shengbai Sun, Bingxin Liu, Mingyue Zhou, Yuan Yin, Zhaohui Huang. Comprehensive Characterization of Integrin Subunit Genes in Human Cancers. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.704067
|
| 23 |
Yi Liu, Guodong Zhao, Jin Miao, Hui Li, Yong Ma, Xiaoyu Liu, Shiming Li, Yun Zhu, Shangmin Xiong, Minxue Zheng, Sujuan Fei. Performance Comparison Between Plasma and Stool Methylated SEPT9 Tests for Detecting Colorectal Cancer. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00324
|
| 24 |
Maryam Alizadeh-Sedigh, Mohammad Sadegh Fazeli, Habibollah Mahmoodzadeh, Shahin Behrouz Sharif, Ladan Teimoori-Toolabi. Methylation of FBN1, SPG20, ITF2, RUNX3, SNCA, MLH1, and SEPT9 genes in circulating cell-free DNA as biomarkers of colorectal cancer. Cancer Biomarkers 2022; 34(2): 221 doi: 10.3233/CBM-210315
|
| 25 |
Aitor Rodriguez-Casanova, Aida Bao-Caamano, Nicolás Costa-Fraga, Laura Muinelo-Romay, Angel Diaz-Lagares. Cancer Metastasis Through the Lymphovascular System. 2022; : 167 doi: 10.1007/978-3-030-93084-4_17
|
| 26 |
M Alizade Naini, P Mokarram, S Kavousipour, N Zare, A Atapour, M Hassan Zarin, G Mehrabani, M Borji. Sensitive and Noninvasive Detection of Aberrant SFRP2 and MGMT-B Methylation in Iranian Patients with Colon Polyps. Asian Pacific Journal of Cancer Prevention 2016; 17(4): 2185 doi: 10.7314/APJCP.2016.17.4.2185
|
| 27 |
Chinasa Valerie Olovo, Xinxiang Huang, Xueming Zheng, Min Xu. Faecal microbial biomarkers in early diagnosis of colorectal cancer. Journal of Cellular and Molecular Medicine 2021; 25(23): 10783 doi: 10.1111/jcmm.17010
|
| 28 |
Xiaofeng Zhai, Qingfeng Xue, Qun Liu, Yuyu Guo, Zhe Chen. Colon cancer recurrence-associated genes revealed by WGCNA co-expression network analysis. Molecular Medicine Reports 2017; 16(5): 6499 doi: 10.3892/mmr.2017.7412
|
| 29 |
Sima Jafarpour, Farideh Saberi, Maryam Yazdi, Reza Nedaeinia, Guilda Amini, Gordon A. Ferns, Rasoul Salehi. Association between colorectal cancer and the degree of ITGA4 promoter methylation in peripheral blood mononuclear cells. Gene Reports 2022; 27: 101580 doi: 10.1016/j.genrep.2022.101580
|
| 30 |
Khatere Mokhtari, Maryam Peymani, Mohsen Rashidi, Kiavash Hushmandi, Kamran Ghaedi, Afshin Taheriazam, Mehrdad Hashemi. Colon cancer transcriptome. Progress in Biophysics and Molecular Biology 2023; : 49 doi: 10.1016/j.pbiomolbio.2023.04.002
|
| 31 |
Qiang Xiao, Yu Yang, Xuepu Zhang, Qing An. Enhanced Wnt signaling by methylation-mediated loss of SFRP2 promotes osteosarcoma cell invasion. Tumor Biology 2016; 37(5): 6315 doi: 10.1007/s13277-015-4466-z
|
| 32 |
Béla Molnár, Orsolya Galamb, Alexandra Kalmár, Barbara Kinga Barták, Zsófia Brigitta Nagy, Kinga Tóth, Zsolt Tulassay, Péter Igaz, Magdolna Dank. Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis - an update. Expert Review of Molecular Diagnostics 2019; 19(6): 477 doi: 10.1080/14737159.2019.1613891
|
| 33 |
Yu Sun, Deyang Kong, Qi Zhang, Renshen Xiang, Shuaibing Lu, Lin Feng, Haizeng Zhang. DNA methylation biomarkers for predicting lymph node metastasis in colorectal cancer. Clinical and Translational Oncology 2024; 27(2): 439 doi: 10.1007/s12094-024-03601-6
|
| 34 |
Qionglin Huang, Qingjin Yang, Mingming Mo, Xiaoxia Ye, Junjie Zhang, Lijian Zhang, Bin Chen, Jian Li, Chun Cai. Screening of exon methylation biomarkers for colorectal cancer via LC‐MS/MS strategy. Journal of Mass Spectrometry 2017; 52(12): 860 doi: 10.1002/jms.4032
|
| 35 |
Mozhdeh Zamani, Seyed Vahid Hosseini, Pooneh Mokarram. Epigenetic biomarkers in colorectal cancer: premises and prospects. Biomarkers 2018; 23(2): 105 doi: 10.1080/1354750X.2016.1252961
|
| 36 |
Yuzhou Zhu, Tinghan Yang, Qingbin Wu, Xuyang Yang, Jianqi Hao, Xiangbing Deng, Shuo Yang, Chaoyang Gu, Ziqiang Wang. Diagnostic performance of various liquid biopsy methods in detecting colorectal cancer: A meta‐analysis. Cancer Medicine 2020; 9(16): 5699 doi: 10.1002/cam4.3276
|
| 37 |
David E. Amacher. A 2015 survey of established or potential epigenetic biomarkers for the accurate detection of human cancers. Biomarkers 2016; 21(5): 387 doi: 10.3109/1354750X.2016.1153724
|
| 38 |
Khalid El Bairi, Kanwal Tariq, Imane Himri, Abdeslam Jaafari, Wiam Smaili, Abdul Hafeez Kandhro, Adel Gouri, Bouchra Ghazi. Decoding colorectal cancer epigenomics. Cancer Genetics 2018; 220: 49 doi: 10.1016/j.cancergen.2017.11.001
|
| 39 |
Stine Dam Henriksen, Poul Henning Madsen, Anders Christian Larsen, Martin Berg Johansen, Inge Søkilde Pedersen, Henrik Krarup, Ole Thorlacius-Ussing. Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinoma. Oncotarget 2017; 8(55): 93942 doi: 10.18632/oncotarget.21397
|
| 40 |
X Zhang, X Rong, Y Chen, L Su. Methylation-mediated loss of SFRP2 enhances invasiveness of non–small cell lung cancer cells. Human & Experimental Toxicology 2018; 37(2): 155 doi: 10.1177/0960327117693071
|
| 41 |
Joel Petit, Georgia Carroll, Tiffany Gould, Peter Pockney, Matthew Dun, Rodney J. Scott. Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review. Journal of Surgical Research 2019; 236: 184 doi: 10.1016/j.jss.2018.11.029
|
| 42 |
Sander Bach, Nina R Sluiter, Jamie J Beagan, Joost M Mekke, Johannes C F Ket, Nicole C T van Grieken, Renske D M Steenbergen, Bauke Ylstra, Geert Kazemier, Jurriaan B Tuynman. Circulating Tumor DNA Analysis: Clinical Implications for Colorectal Cancer Patients. A Systematic Review. JNCI Cancer Spectrum 2019; 3(3) doi: 10.1093/jncics/pkz042
|
| 43 |
Xianglin Liu, Jialing Wen, Chujun Li, Hui Wang, Jianping Wang, Hongzhi Zou. High-Yield Methylation Markers for Stool-Based Detection of Colorectal Cancer. Digestive Diseases and Sciences 2020; 65(6): 1710 doi: 10.1007/s10620-019-05908-9
|
| 44 |
Zuojian Hu, Junrong Wu, Shaolin Tan, Lujie Yang, Junhui Huang, Cuiju Mo, Huaping Chen, Xuelian Ruan, Xue Qin. Diagnostic value of long noncoding RNA LINC01485 in patients with colorectal cancer. Clinical Biochemistry 2022; 102: 34 doi: 10.1016/j.clinbiochem.2022.01.003
|
| 45 |
Maartje Massen, Kim Lommen, Kim A. D. Wouters, Johan Vandersmissen, Wim van Criekinge, James G. Herman, Veerle Melotte, Leo J. Schouten, Manon van Engeland, Kim M. Smits. Technical considerations in PCR-based assay design for diagnostic DNA methylation cancer biomarkers. Clinical Epigenetics 2022; 14(1) doi: 10.1186/s13148-022-01273-z
|
| 46 |
Marcela Chmelarova, Jan Laco, Helena Kovarikova, Ivana Baranova, Pavel Dundr, Kristyna Nemejcova, Jaroslav Michalek, Milan Vosmik, Vladimir Palicka. Elevated DNA methylation in malignant tumors of the sinonasal tract and its association with patient survival. Biomedical Papers 2018; 162(3): 232 doi: 10.5507/bp.2018.012
|
| 47 |
The Silencing of SFRP2 Expression in ESCC Is Due to Methylation of the Gene Promoter. Technology in Cancer Research & Treatment 2019; 18 doi: 10.1177/1533033819877977
|
| 48 |
Qihua Yang, Tao Huang, Guoliang Ye, Bojun Wang, Xinjun Zhang. Methylation of SFRP2 gene as a promising noninvasive biomarker using feces in colorectal cancer diagnosis: a systematic meta-analysis. Scientific Reports 2016; 6(1) doi: 10.1038/srep33339
|
| 49 |
Qinghua Wang, Zelin Liu, Guanzhong Zhai, Xi Yu, Shuai Ke, Haoren Shao, Jia Guo. Overexpression of GATA5 Inhibits Prostate Cancer Progression by Regulating PLAGL2 via the FAK/PI3K/AKT Pathway. Cancers 2022; 14(9): 2074 doi: 10.3390/cancers14092074
|